PlainRecalls
FDA Devices Moderate Class II Ongoing

Access Thyroglobulin Antibody II, REF A32898, containing Instructions for Use, IFU REF B14994, B63978, and A38168. The Access Thyroglobulin Antibody II (TgAb) assay is used for the quantitative determination of thyroglobulin antibody levels in human serum and plasma using the Access Immunoassay Systems.

Reported: November 6, 2024 Initiated: September 5, 2024 #Z-0265-2025

Product Description

Access Thyroglobulin Antibody II, REF A32898, containing Instructions for Use, IFU REF B14994, B63978, and A38168. The Access Thyroglobulin Antibody II (TgAb) assay is used for the quantitative determination of thyroglobulin antibody levels in human serum and plasma using the Access Immunoassay Systems.

Reason for Recall

IFUs for the device incorrectly states the biotin interference was remediated. The issue could result in potentially false-low results.

Details

Recalling Firm
Beckman Coulter, Inc.
Units Affected
465,481 kits
Distribution
Distribution was made nationwide to the U.S., including Puerto Rico. There was government distribution but no military distribution. Foreign distribution was made to Mexico.
Location
Chaska, MN

Frequently Asked Questions

What product was recalled?
Access Thyroglobulin Antibody II, REF A32898, containing Instructions for Use, IFU REF B14994, B63978, and A38168. The Access Thyroglobulin Antibody II (TgAb) assay is used for the quantitative determination of thyroglobulin antibody levels in human serum and plasma using the Access Immunoassay Systems.. Recalled by Beckman Coulter, Inc.. Units affected: 465,481 kits.
Why was this product recalled?
IFUs for the device incorrectly states the biotin interference was remediated. The issue could result in potentially false-low results.
Which agency issued this recall?
This recall was issued by the FDA Devices on November 6, 2024. Severity: Moderate. Recall number: Z-0265-2025.